A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Clinical Trial ID NCT01839604

Rank	Title	Journal	Year	PubWeight™‹?›
1	MicroRNAome genome: a treasure for cancer diagnosis and therapy.	CA Cancer J Clin	2014	1.40
2	STAT inhibitors for cancer therapy.	J Hematol Oncol	2013	1.16
3	Targeting tumor-infiltrating macrophages to combat cancer.	Immunotherapy	2013	0.91
4	Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer.	Cancer Growth Metastasis	2015	0.90
5	Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.	Nucleic Acids Res	2015	0.88
6	Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.	PLoS One	2015	0.84
7	Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.	Int J Clin Exp Med	2015	0.81
8	Signal transducer and activator of transcription 3 signaling as a potential target to treat muscle wasting diseases.	Curr Opin Clin Nutr Metab Care	2016	0.81
9	Immunobiology of hepatocarcinogenesis: Ways to go or almost there?	World J Gastrointest Pathophysiol	2016	0.76
10	An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.	Int J Genomics	2015	0.75